Guillaume Connan
Directeur Général chez Helse SAS
Profil
Guillaume Connan is currently the Chairman at Chabé Limousines SAS, Chairman at Connan Bonvallet Conseil, Director at Galien Développement SA, and Managing Director at Helse SAS since 2012.
He previously worked as Chairman at Xeltis AG, Director at Nautilus Biotech SA, Director-Investments at Matignon Investissement et Gestion SAS from 2000 to 2010, and Director at Kaneka Eurogentec SA. He also briefly served as Director at QIAGEN Marseille SA in 2010.
Mr. Connan received his undergraduate degree and MBA from École des Hautes Études Commerciales de Paris.
Postes actifs de Guillaume Connan
| Sociétés | Poste | Début |
|---|---|---|
| Helse SAS | Directeur Général | 09/05/2011 |
Galien Développement SA
 Galien Développement SA Miscellaneous Commercial ServicesCommercial Services Galien Développement SA provides management and financial services to pharmacies. The company was founded by Benoît Bouche on October 30, 2008 and is headquartered in Aix-en-Provence, France. | Directeur/Membre du Conseil | - |
Chabé Limousines SAS
 Chabé Limousines SAS Other TransportationTransportation Chabé Limousines SAS provides luxury transportation and car leasing services. It offers limousines and other cars available for rent. The company was founded by Maurice Chabé in 1921 and is headquartered in Paris, France. | Président | - |
| Connan Bonvallet Conseil | Président | - |
Anciens postes connus de Guillaume Connan
| Sociétés | Poste | Fin |
|---|---|---|
Nautilus Biotech SA
 Nautilus Biotech SA Pharmaceuticals: MajorHealth Technology Nautilus Biotech SA develops and markets innovative biotechnology products. The company focuses on improving and developing protein pharmaceuticals. The firm was founded in 1999 and is headquartered in Evry, France. | Directeur/Membre du Conseil | 10/03/2010 |
Matignon Investissement et Gestion SAS
 Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Private Equity Investor | 21/01/2010 |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Président | - |
Kaneka Eurogentec SA
 Kaneka Eurogentec SA BiotechnologyHealth Technology Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium. | Directeur/Membre du Conseil | - |
| QIAGEN MARSEILLE | Directeur/Membre du Conseil | - |
Formation de Guillaume Connan
| École des Hautes Études Commerciales de Paris | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Nautilus Biotech SA
Nautilus Biotech SA Pharmaceuticals: MajorHealth Technology Nautilus Biotech SA develops and markets innovative biotechnology products. The company focuses on improving and developing protein pharmaceuticals. The firm was founded in 1999 and is headquartered in Evry, France. | Health Technology |
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Kaneka Eurogentec SA
Kaneka Eurogentec SA BiotechnologyHealth Technology Kaneka Eurogentec SA distributes reagents, kits and other related products for the biotechnology, pharmaceutical, and diagnostic sectors. It offers a range of services, from basic research in genomics and proteomics, to services associated with the development and manufacture of diagnostic and therapeutic products. The company was founded in 1985 and is headquartered in Seraing, Belgium. | Health Technology |
QIAGEN Marseille SA
 QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services QIAGEN Marseille SA is a molecular diagnosis company, which focuses on the development and marketing of diagnostic tests in the field of oncology. Its products are used for diagnosis, prognosis and monitoring of patients with leukemia. The company was founded by Vincent Fert, Stéphane Debono, and Fabienne Hermitte on September 23, 1999 and is headquartered in Marseille, France. | Commercial Services |
Chabé Limousines SAS
Chabé Limousines SAS Other TransportationTransportation Chabé Limousines SAS provides luxury transportation and car leasing services. It offers limousines and other cars available for rent. The company was founded by Maurice Chabé in 1921 and is headquartered in Paris, France. | Transportation |
Galien Développement SA
Galien Développement SA Miscellaneous Commercial ServicesCommercial Services Galien Développement SA provides management and financial services to pharmacies. The company was founded by Benoît Bouche on October 30, 2008 and is headquartered in Aix-en-Provence, France. | Commercial Services |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
| Connan Bonvallet Conseil | |
| Helse SAS | Finance |
